Results From Randomized Clinical Trial Do Not Support Hydroxychloroquine for COVID-19

Adverse events were more common in those receiving the drug. The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in...
The post Results From Randomized Clinical Trial Do Not Support Hydroxychloroquine for COVID-19 appeared first on SciTechDaily.